Literature DB >> 921356

Metastatic carcinomas from occult primary tumors. A study of 254 patients.

M S Didolkar, N Fanous, E G Elias, R H Moore.   

Abstract

From 1950 to 1973, 254 patients with metastatic cancers from occult primary tumors, comprising 0.5% of all the referred cancer patients were seen. The average age was 59 years. Clinical presentation was commonly in the form of metastatic lesions in lung, cervical lymph node, bone or liver. Radiological and radioisotopic investigations proved helpful in determining the extent of disease rather than the origin of primary tumor. Adenocarcinoma was the commonest type, followed by undifferentiated and squamous cell carcinomas. The origin of the primary tumor was established in 77 (30%) patients, mostly at autopsy. It was in the lung in 40% of the cases, followed by stomach, pancreas, kidney, ovary and colon. Some correlation was found between clinical presentation and the origin of the primary tumor. Histologically different second cancers were detected in 28 (11%) patients. Overall median and five-year survival rates were nine months and nine per cent respectively. Longer survival was seen in patients with squamous cell carcinoma metastases, middle and upper neck lymph node lesions, and those who had "curative" surgery. In localized metastatic lesions, surgical extirpation should be done. Depending on the histological type of the metastatic lesions, chemotherapy and/or radiation therapy have definite roles in the management of these patients. Periodic follow-up examinations also prove valuable.

Entities:  

Mesh:

Year:  1977        PMID: 921356      PMCID: PMC1396304          DOI: 10.1097/00000658-197711000-00014

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  10 in total

1.  RESPONSE OF PRIMARY UNKNOWN CANCERS TO TREATMENT WITH 5-FLUOROURACIL (NSC-19893).

Authors:  R O JOHNSON; R CASTRO; F J ANSFIELD
Journal:  Cancer Chemother Rep       Date:  1964-05

2.  CARCINOMA OF THE NECK.

Authors:  F C MARCHETTA; W T MURPHY; J J KOVARIC
Journal:  Am J Surg       Date:  1963-12       Impact factor: 2.565

3.  Tumours of unknown origin.

Authors:  A C Templeton
Journal:  Recent Results Cancer Res       Date:  1973

Review 4.  Metastatic neoplasms to the head and neck.

Authors:  J G Batsakis; T A McBurney
Journal:  Surg Gynecol Obstet       Date:  1971-10

5.  Cervical lymph node metastasis: unknown primary cancer.

Authors:  R H Jesse; C A Perez; G H Fletcher
Journal:  Cancer       Date:  1973-04       Impact factor: 6.860

6.  Treatment of the patient with adenocarcinoma of unknown origin.

Authors:  C G Moertel; R J Reitemeier; A J Schutt; R G Hahn
Journal:  Cancer       Date:  1972-12       Impact factor: 6.860

7.  Chemotherapy in the management of metastatic cancer of unknown primary site.

Authors:  V C Lleander; G Goldstein; J S Horsley
Journal:  Oncology       Date:  1972       Impact factor: 2.935

8.  Metastatic cancer of unknown primary site.

Authors:  F F Holmes; T L Fouts
Journal:  Cancer       Date:  1970-10       Impact factor: 6.860

9.  Metastatic cancer without a detectable primary site.

Authors:  P E Smith; E T Krementz; W Chapman
Journal:  Am J Surg       Date:  1967-05       Impact factor: 2.565

10.  Metastatic potential of metastases.

Authors:  J A Roth; M J Silverstein; D L Morton
Journal:  Surgery       Date:  1976-06       Impact factor: 3.982

  10 in total
  19 in total

1.  FNAB of metastatic lesions with special reference to clinicopathological analysis of primary site in cases of epithelial and non-epithelial tumors.

Authors:  Shamshad Ahmad; Kafil Akhtar; Swati Singh; Shahid Siddiqui
Journal:  J Cytol       Date:  2011-04       Impact factor: 1.000

2.  Role of 18F-FDG PET-CT imaging for the detection of an unknown primary tumour: preliminary results in 21 patients.

Authors:  C Nanni; D Rubello; P Castellucci; M Farsad; R Franchi; S Toso; C Barile; L Rampin; O Nibale; S Fanti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-02-22       Impact factor: 9.236

3.  Chasing the unknown primary.

Authors: 
Journal:  Br Med J       Date:  1980-11-08

4.  Carcinoid tumours: predicting the location of the primary neoplasm based on the sites of metastases.

Authors:  P Bhosale; A Shah; W Wei; G Varadhachary; V Johnson; V Shah; V Kundra
Journal:  Eur Radiol       Date:  2012-08-30       Impact factor: 5.315

Review 5.  Carcinomas of an unknown primary origin--diagnosis and treatment.

Authors:  Christophe Massard; Yohann Loriot; Karim Fizazi
Journal:  Nat Rev Clin Oncol       Date:  2011-11-01       Impact factor: 66.675

6.  Mediastinal lymph node carcinoma of an unknown primary site: clinicopathological examination.

Authors:  Ken Miwa; Shinji Fujioka; Yoshin Adachi; Tomohiro Haruki; Yuji Taniguchi; Hiroshige Nakamura
Journal:  Gen Thorac Cardiovasc Surg       Date:  2009-05-15

7.  Detection of unknown primary neuroendocrine tumours (CUP-NET) using (68)Ga-DOTA-NOC receptor PET/CT.

Authors:  Vikas Prasad; Valentina Ambrosini; Merten Hommann; Dieter Hoersch; Stefano Fanti; Richard P Baum
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-01       Impact factor: 9.236

8.  Long-term survival after incomplete resection of immunohistochemically diagnosed T0N1 lung cancer: report of a case.

Authors:  Yotaro Izumi; Makio Mukai; Koji Kikuchi; Koichi Kobayashi
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

9.  The value of immunohistochemistry in patients with poorly differentiated adenocarcinomas and undifferentiated carcinomas of unknown primary.

Authors:  A van der Gaast; J Verwij; A S Planting; G Stoter; S C Henzen-Logmans
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

10.  Metastatic bone disease from occult carcinoma: a profile.

Authors:  M Nottebaert; G U Exner; A R von Hochstetter; A Schreiber
Journal:  Int Orthop       Date:  1989       Impact factor: 3.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.